-
-
-
-
-
Executive committee
-
-
-
-
-
-
-
-
-
european network for the study of adrenal tumors
Executive committee
Chair of the Executive Committee
Martin Fassnacht, MD
Head of the Division of Endocrinology and Diabetes
Department of Internal Medicine I
University Hospital Würzburg
Oberdürrbacherstr. 6
Würzburg, Germany
Martin Fassnacht is Professor of Internal Medicine and Endocrinology at the University of Würzburg. He is head of the Division of Endocrinology and Diabetes at the University Hospital Würzburg. The main interest of his clinical and translational research group is endocrine tumors with a special focus on adrenal tumors. He run(s) several clinical trials for patients with adrenocortical carcinoma and malignant pheochromocytoma and his translational group is adrenocortical tumorigenesis and drug targets for adrenocortical carcinoma.
Period in office: 2016-2019
Secretary
Tracy Ann Williams, BSc, PhD
Division of Internal Medicine and Hypertension
Department of Medical Sciences
University of Torino
Via Giuseppe Verdi 8
Torino, Italy
Dr. Williams heads the laboratory of genetics and molecular biology of hypertension in the Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Italy. She is visiting research scientist at the Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians University in Munich. Her main interests are monogenic forms of hypertension and disorders of aldosterone production centering on aldosterone-producing adenomas.
Period in office: 2018-2022
Treasurer
Anne-Paule Gimenez-Roqueplo, MD, PhD
INSERM UMR 970
or/ Service de Génétique
Hôpital européen Georges Pompidou
rue Leblanc
Paris, France
Professor Anne-Paule Gimenez-Roqueplo (MD, specialized in Endocrinology, PhD in Genetics) is Full Professor in Genetics at Paris Descartes University. She is responsible of the Oncogenetic activity (molecular tests and multidisciplinary counsultation) in the Genetics department of Hôpital Européen Georges Pompidou (Paris, France). Her main interests are benign and malignant pheochromocytomas and paragangliomas (PPGL). She is the Director of an academic research team entitled “Pheochromocytomas and Paragangliomas, from Genetics to Molecular Targeted Therapies” within the INSERM Unit 970 at the Paris Cardiovascular Center at HEGP (PARCC@HEGP), Paris, France (http://parcc.inserm.fr/). She is the coordinator of PGL.R, the National French registry for SDHx-related paragangliomas.
Period in office: 2013-2019
Other members of the Executive Committee
Pr Guillaume Assié
Endocrine department, Cochin hospital, APHP, Paris
Institut Cochin, Inserm CNRS, Université de Paris
Paris, France
Guillaume Assié is professor of Endocrinology in Université de Paris, working in the Endocrine department of Cochin hospital in Paris. He is specialized in general Endocrinology, mainly Cushing syndromes, adrenal tumors, and pituitary diseases.
His research activity is mainly focused on bioinformatics, mainly working on the genomic alterations of endocrine tumors, including adrenal tumors.
Period in office: 2019-2022Heads of working groups
ACC Working Group
Felix Beuschlein, MD
Endocrine Research
Unit
Medizinische Klinik
und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany
Felix Beuschlein is Professor of Internal Medicine/Endocrinology, Head of the Endocrine Research Unit and runs the Endocrine Outpatient Clinic at the University Hospital in Munich. His main scientific interest pertain to all fields of adrenal research including adrenocortical carcinoma, primary aldosteronism, Cushing’s syndrome and pheochromocytoma. He has served as the chairman of ENSAT between 2008 and 2016 and has led an FP7 funded consortium on adrenal tumors (ENSAT-CANCER).
Period in office: 2016-2019
Pheo/PPGL Working Group
Mercedes Robledo, PhD
Hereditary Endocrine Cancer, Group Leader
Human Cancer Genetics Programme
Spanish National Cancer Centre (CNIO)
C/ Melchor Fernández Almagro 3
Madrid, Spain
Mercedes Robledo is the head of the Hereditary Endocrine Cancer Group, in the Human Genetics Cancer Program at the Spanish National Cancer Center (CNIO), Madrid, Spain. Her Group is interested in identifying high and low genetic risk factors involved in pheochromocytoma and thyroid cancer susceptibility. To this end, we analyse tumour samples and look for differences between genomic features according to the different individual genetic backgrounds. Such comprehensive characterisation allows us, not only to define diagnostic and prognostic markers associated with primary mutations, but also to pinpoint specific altered pathways that can lead to the identification of future therapeutic targets.
Period in office: 2017-2020
NAPACA Working Group
Wiebke Arlt, MD, DSc., FRCP, FMedSci
Institute of Metabolism and Systems Research (IMSR)
University of Birmingham
& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)
Birmingham Health Partners
Birmingham, UK
Professor Wiebke Arlt is William Withering Chair of Medicine and Director of the Institute of Metabolism and Systems Research at the University of Birmingham, UK. She leads a multi-disciplinary research group focussing on steroid endocrinology in the context of adrenal and gonadal disorders. She is a Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her main interests are adrenal incidentaloma, adrenocortical carcinoma and adrenal steroid excess syndromes.
Period in office: 2017-2020
APA Working Group
Martin Reincke, MD
Medizinische Klinik und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany
Martin Heinrich Reincke is the director of the Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians University in Munich and Chair of the Department of Endocrinology and Diabetology..
His research focus includes adrenal physiology and pathophysiology, endocrine hypertension, pituitary disease, mineralocorticoid and glucocorticoid action and stress research. Professor Reincke is heading a research team specifically exploring the prevalence and relevance of mineralocorticoid excess in resistant hypertension on the epidemiological, clinical, genetic and molecular level.
Professor Reincke is a member of many national and international societies, including the Endocrine Society, European Society of Endocrinology and European Network of the study of adrenal tumors. He has served in the Executive Board of the German Endocrine Society and European Society of Endocrinology, is on the editorial board of several international journals, and has served as teaching dean of the faculty from 2006-2012.
He has published more than 380 Medline listed publications cited >9200 times, his h-index is 53.Period in office: 2017-2020
Chairs of local ENSAT scientific meetings committees
Björklund Peyman, 18th ENS@T meeting 2019, Uppsala, Sweden. Period in office: 2017-2019
Felix Beuschlein, 19th ENS@T meeting 2020, Munich, Germany. Period in office: 2018-2020
Aleksander Prejgisz, 20th ENS@T meeting 2021, Warsaw, Poland. Period in office: 2019-2021
---------------------------------------------------------------------------------------------------------------------------------------------
Former Chairs of the Executive Committee:
Felix Beuschlein, Munich, Germany. Period in office: 2009-2016
Former members of the Executive Committee:
Giuseppe Opocher, MD
Familial Cancer Clinic and Oncoendocrinology
Veneto Institute of Oncology
University of Padova
Via Gattamelata 64
Padova, Veneto, Italy
Period in office: 2014-2018
Henri Timmers, MD, PhD
Division of Endocrinology
Department of Internal Medicine
Radboud University Medical Centre
Geert Grooteplein Zuid 8
Radboud, The Netherlands
Henri Timmers (1971), M.D./Ph.D., is clinical endocrinologist and assistant professor at the Department of Medicine, section of Endocrinology, Radboud University Medical Centre, in Nijmegen, the Netherlands. He is head of the Radboud Adrenal Center and member of the steering committees of ENS@T and the international Pheochromocytoma and Paraganglioma Research Support Organization (PRESSOR). His principle clinical and scientific focus is on adrenal diseases, especially pheochromocytoma and paraganglioma.
Former Secretary of ENS@T. Period in office: 2011-2017
Jérôme Bertherat, MD, PhD
Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre National de la Recherche Scientifique (CNRS)
Institut Cochin, Université Paris-Descartes
22, rue Mechain
Paris, France
Period in office: 2009-2016
Wiebke Arlt, Birmingham, UK. Period in office: 2009-2016
Massimo Terzolo, MD
Head of Department of Internal Medicine I
University of Torino
Regione Gonzole 10
Torino, Italy
Period in office: 2009-2014
Massimo Mannelli, Florence, Italy. Period in office: 2009-2011
Former chairs of local ENSAT scientific meetings committees
Massimo Manelli
17th ENS@T meeting 2018, Florence, Italy.
Prof. Mannelli is Full Professor of Endocrinology in the Department of Experimental and Clinical Biomedical Sciences, University of Florence. He is the Director of the Clinical Endocrine Unit at the Azienda Ospedaliera-Universitaria Careggi, Florence. He has served as Director of the Post-graduate School of Endocrinology, University of Florence. His main research interests are pheochromocytoma/paragangliomas and adrenocortical cancer.He is coordinator of the Pheochromocytoma/Paraganglioma working group of the Italian Endocrine Society.
Period in office: 2017-2018
Founding Executive Committee Members (2002-2009)
Bruno Allolio, Würzburg, Germany
Xavier-Yves Bertagna, Paris, France
Massimo Manelli, Florence, Italy
Franco Mantero, Padua, Italy
Pierre-Francois Plouin, Paris, France
Paul M. Stewart, Leeds, UK
Martin Reincke, Munich, Germany